NC A&T and PTRM Engine Leadership Unite to Advance Bioinks and Biomanufacturing
From digital twins to 3D bioprinting, robotics to holographs, NSF-PTRM Engine partner North Carolina A&T recently hosted members of the Engine Leadership team for constructive discussions about biomanufacturing, bioinks, and workforce development. The university is leading the charge on advancing bioinks, a critical component in 3D bioprinting.
Charter Medical Expands Lab Capabilities in IQ, Accelerating Innovation in Biosafety and Cryopreservation for the NSF-PTRM Engine
Charter Medical is continuing to push the boundaries of innovation for its customers’ applications. It recently added a new biosafety cabinet at Sparq Labs in the Innovation Quarter (IQ) of Winston-Salem. This enhances Charter’s capacity to explore live cell work within their single-use design services and cryopreservation studies. Charter Medical joined Sparq Labs in March 2024 […]
Winston-Salem State University Awarded NSF EPIIC Grant to Strengthen Workforce Development
Winston-Salem State University (WSSU) was awarded a $370,000 grant to better prepare students for STEM jobs. The award is a part of the U.S. National Science Foundation’s Enabling Partnerships to Increase Innovation Capacity (EPIIC) program, which announced an investment of nearly $19 million to 48 awardees at U.S. institutions of higher education, including historically Black colleges […]
Cancer Research in Space for Life on Earth
The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS). The project, one of only five chosen through a competitive solicitation by the ISS National Lab in partnership with NASA, aims to explore the effects of microgravity on cancer development and treatment.
ProKidney Accelerates U.S. FDA Pathway for Rilparencel, Boosting the Regenerative Medicine Ecosystem Supported by NSF Engine
ProKidney Corp., a clinical-stage biotech company at the forefront of regenerative medicine, has announced strategic updates to its Phase 3 program for rilparencel, a pioneering cell therapy aimed at treating type 2 diabetes and advanced chronic kidney disease (CKD). After extensive consultation with regulatory experts, ProKidney has chosen to focus on the ongoing Phase 3 […]
Congratulations to Brinter AM Technologies: Advancing the NSF Engine’s Mission with 3D Bioprinting on the ISS
We are proud to congratulate Brinter AM Technologies on their significant contribution as an NSF partner, providing a state-of-the-art 3D bioprinter for Advanced Tissue Manufacturing on the International Space Station (ISS) as part of an ESA project. This milestone underscores Brinter’s vital role in moving the NSF Engine forward. With a strong commitment to advancing […]
Biotech Executive and Serial Entrepreneur Appointed to Lead NSF Program Commercializing Technologies from Leading North Carolina Institutions
The Wake Forest Institute for Regenerative Medicine (WFIRM) proudly announces the appointment of Tim Bertram, PhD, as its new Chief Ecosystem Officer. He will serve as the Chief Executive Officer (CEO) of the U.S. National Science Foundation (NSF) multi-million-dollar long-term investment in commercializing advanced regenerative medical technologies from leading North Carolina academic institutions. With an illustrious career marked by innovation and leadership, Bertram brings decades of transformative experience from his tenure at ProKidney, a leading chronic kidney disease therapy company he founded focused on preserving kidney function and controlling kidney failure.
Wake Forest Institute for Regenerative Medicine Collaborates on $18 Million NSF Grant to Combat Future Pandemics
The Wake Forest Institute for Regenerative Medicine (WFIRM) is proud to be part of a new initiative, supported by an $18 million grant from the U.S. National Science Foundation (NSF), aimed at enhancing global pandemic prediction and prevention capabilities. This grant brings together five leading universities and more than 20 researchers, academics, and public health […]
Advancing Limb Preservation Research to Support NSF Innovation Engine
BMI OrganBank™ has partnered on a $1.5 million project to develop innovative methods for preserving human limbs for transplantation. The research aims to extend tissue viability, enhancing transplant outcomes for critical tissues like skin, bone, and nerves. This breakthrough has the potential to significantly impact the NSF Innovation Engine’s goals by contributing to advancements in […]
FetTech, LLC to bring biomaterials expertise to the NSF-PTRME Ecosystem as new Test Bed partner
FetTech, LLC, a manufacturer of materials for regenerative medicine therapies, is bringing their expertise to the NSF-Piedmont Triad RegenMed Engine (PTRME) ecosystem. This collaboration aims to enhance the development and clinical translation of innovative therapies using FetTech’s Multi-Tissue Platform (MTP) technology.